Senses Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.05 Cr
as on 03-07-2024
- Paid Up Capital ₹ 1.11 M
as on 03-07-2024
- Company Age 16 Year, 24 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.64 Cr
as on 03-07-2024
- Satisfied Charges ₹ 2.25 Cr
as on 03-07-2024
- Revenue 52.39%
(FY 2023)
- Profit 124.08%
(FY 2023)
- Ebitda 163.06%
(FY 2023)
- Net Worth 6.73%
(FY 2023)
- Total Assets 21.93%
(FY 2023)
About Senses Pharmaceuticals
The Corporate was formerly known as Senses Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.05 Cr and a paid-up capital of Rs 1.11 M.
The company currently has active open charges totaling ₹8.64 Cr. The company has closed loans amounting to ₹2.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Velayudham Suresh, Kapil Jhaver, Rangarajan Vijayaragavan, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232KA2008PTC048422
- Company No.
048422
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore North, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Senses Pharmaceuticals Private Limited offer?
Senses Pharmaceuticals Private Limited offers a wide range of products and services, including Oils, Grease & Lubricants, Hydraulic Oils, Common Disease Medicines, Eye Drops, Digestive System Drugs & Medicines, Antacid Drugs, Nutraceuticals & Dietary Supplements, Nutraceuticals, Medical & Surgical Clothing, OT Linen.
Who are the key members and board of directors at Senses Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Velayudham Suresh  | Director | 04-Apr-2018 | Current |
| Kapil Jhaver | Director | 09-Jun-2020 | Current |
| Rangarajan Vijayaragavan | Director | 10-Jun-2022 | Current |
| Sundaresan Rajagopalan | Director | 26-Nov-2008 | Current |
Financial Performance and Corporate Structure Insights of Senses Pharmaceuticals.
Senses Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.39% increase. The company also saw a substantial improvement in profitability, with a 124.08% increase in profit. The company's net worth moved up by a moderate rise of 6.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Senses Pharmaceuticals?
In 2023, Senses Pharmaceuticals had a promoter holding of 40.13% and a public holding of 59.87%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Transe Vision Care Private LimitedActive 12 years 9 monthsKapil Jhaver, Rangarajan Vijayaragavan and 1 more are mutual person
Til Healthcare Private LimitedActive 33 years 10 monthsKapil Jhaver and Rangarajan Vijayaragavan are mutual person
Quest Teleradiology Solutions Private LimitedActive 11 years 10 monthsVelayudham Suresh and Sundaresan Rajagopalan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 05 May 2015 | ₹8.64 Cr | Open |
Others Creation Date: 12 Apr 2016 | ₹2.50 M | Satisfied |
State Bank Of India Creation Date: 10 Sep 2009 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Senses Pharmaceuticals?
Senses Pharmaceuticals has a workforce of 154 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Senses Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Senses Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
